Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-07-25 | Mr. Guiheen holds a Bachelor of Arts degree in business administration from Rutgers University. Mr. Guiheen was chosen to serve on the Board of Directors because of his extensive experience in the plasma and pharmaceutical industries. |
| 2014-04-29 | Mr. Guiheen is a director of the Company. |
| 2015-04-30 | Mr. Guiheen holds a Bachelor of Arts degree in business administration from Rutgers University. |
| 2016-04-29 | Mr. Guiheen holds a Bachelor of Arts degree in business administration from Rutgers University and has extensive experience in the plasma and pharmaceutical industries. |
| 2018-04-27 | Mr. Guiheen holds a B.A. degree in business administration from Rutgers University. Mr. Guiheen was chosen to serve on the Board because of his extensive experience in the plasma and pharmaceutical industries. |
| 2019-04-24 | Mr. Guiheen has over 30 years of experience in the blood and plasma industry. He holds a B.A. degree in business administration from Rutgers University. |
| 2019-07-16 | Mr. Guiheen is a director and joint trustee of the Guiheen Trust with no mention of software or technical skills. |
| 2020-04-29 | Mr. Guiheen holds a Bachelor of Arts degree in business administration from Rutgers University. |
| 2021-04-07 | Mr. Guiheen holds a Bachelor of Arts degree in business administration from Rutgers University. |
| 2022-04-28 | Mr. Guiheen became a director of the Company in July 2012 with over 35 years of experience in Healthcare Industry. He holds a Bachelor of Arts degree in Business Administration from Rutgers University. |
| 2023-04-13 | Mr. Guiheen holds a Bachelor of Arts degree in Business Administration from Rutgers University. Mr. Guiheen was chosen to serve on the Board of Directors because of his extensive experience in the plasma and pharmaceutical industries. |
| 2024-04-15 | Mr. Guiheen holds a Bachelor of Arts degree in Business Administration from Rutgers University. Mr. Guiheen was chosen to serve on the Board of Directors because of his extensive experience in the plasma and pharmaceutical industries. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-19